File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/MCP.0b013e3283375727
- Scopus: eid_2-s2.0-77951034603
- PMID: 20375785
- WOS: WOS:000276954000010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Features of the new pandemic influenza A/H1N1/2009 virus: Virology, epidemiology, clinical and public health aspects
Title | Features of the new pandemic influenza A/H1N1/2009 virus: Virology, epidemiology, clinical and public health aspects |
---|---|
Authors | |
Keywords | Epidemiology H1N1/2009 Influenza Pandemic Seasonality |
Issue Date | 2010 |
Publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.co-pulmonarymedicine.com |
Citation | Current Opinion In Pulmonary Medicine, 2010, v. 16 n. 3, p. 235-241 How to Cite? |
Abstract | Purpose of Review: The emergence of the pandemic A/H1N1/2009 influenza virus has enabled preexisting pandemic influenza plans to be put into action. This review examines the clinical and public health impact of this new virus. Recent Findings: Although early figures suggested that this pandemic virus was causing higher morbidity and mortality than seasonal influenza viruses, subsequent studies have found it to cause milder disease in most cases. Yet, there are some groups with increased risk of serious disease from this new pathogen. The widespread use of antiviral agents, prophylactically and therapeutically, has led to the sporadic emergence of drug resistance, though this is still rare. Nonpharmacological public health interventions for containment and mitigation have been relatively ineffective in limiting the rapid, global spread of this pathogen. Recently, the focus has been on the manufacture and distribution of various specific vaccines against this new virus, and the care of severely ill patients admitted to intensive care. Summary: As this virus continues to infect new members of the global population, it may eventually become just one of the annual circulating seasonal influenza viruses. Until then, it will be prudent to continue to monitor it closely for any signs of enhanced transmissibility and virulence. © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins. |
Persistent Identifier | http://hdl.handle.net/10722/182373 |
ISSN | 2023 Impact Factor: 2.8 2023 SCImago Journal Rankings: 0.949 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tang, JW | en_US |
dc.contributor.author | Shetty, N | en_US |
dc.contributor.author | Lam, TTY | en_US |
dc.date.accessioned | 2013-04-23T08:21:10Z | - |
dc.date.available | 2013-04-23T08:21:10Z | - |
dc.date.issued | 2010 | en_US |
dc.identifier.citation | Current Opinion In Pulmonary Medicine, 2010, v. 16 n. 3, p. 235-241 | en_US |
dc.identifier.issn | 1070-5287 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/182373 | - |
dc.description.abstract | Purpose of Review: The emergence of the pandemic A/H1N1/2009 influenza virus has enabled preexisting pandemic influenza plans to be put into action. This review examines the clinical and public health impact of this new virus. Recent Findings: Although early figures suggested that this pandemic virus was causing higher morbidity and mortality than seasonal influenza viruses, subsequent studies have found it to cause milder disease in most cases. Yet, there are some groups with increased risk of serious disease from this new pathogen. The widespread use of antiviral agents, prophylactically and therapeutically, has led to the sporadic emergence of drug resistance, though this is still rare. Nonpharmacological public health interventions for containment and mitigation have been relatively ineffective in limiting the rapid, global spread of this pathogen. Recently, the focus has been on the manufacture and distribution of various specific vaccines against this new virus, and the care of severely ill patients admitted to intensive care. Summary: As this virus continues to infect new members of the global population, it may eventually become just one of the annual circulating seasonal influenza viruses. Until then, it will be prudent to continue to monitor it closely for any signs of enhanced transmissibility and virulence. © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins. | en_US |
dc.language | eng | en_US |
dc.publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.co-pulmonarymedicine.com | en_US |
dc.relation.ispartof | Current Opinion in Pulmonary Medicine | en_US |
dc.subject | Epidemiology | - |
dc.subject | H1N1/2009 | - |
dc.subject | Influenza | - |
dc.subject | Pandemic | - |
dc.subject | Seasonality | - |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Antiviral Agents - Therapeutic Use | en_US |
dc.subject.mesh | Communicable Disease Control - Trends | en_US |
dc.subject.mesh | Disease Outbreaks - Prevention & Control - Statistics & Numerical Data | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-Up Studies | en_US |
dc.subject.mesh | Forecasting | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Incidence | en_US |
dc.subject.mesh | Influenza A Virus, H1n1 Subtype - Drug Effects - Isolation & Purification | en_US |
dc.subject.mesh | Influenza Vaccines - Administration & Dosage | en_US |
dc.subject.mesh | Influenza, Human - Epidemiology - Prevention & Control - Virology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Primary Prevention - Methods | en_US |
dc.subject.mesh | Public Health | en_US |
dc.subject.mesh | Risk Assessment | en_US |
dc.subject.mesh | Survival Analysis | en_US |
dc.subject.mesh | Swine | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.subject.mesh | Vaccination - Methods | en_US |
dc.title | Features of the new pandemic influenza A/H1N1/2009 virus: Virology, epidemiology, clinical and public health aspects | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lam, TTY: ttylam@hku.hk | en_US |
dc.identifier.authority | Lam, TTY=rp01733 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1097/MCP.0b013e3283375727 | en_US |
dc.identifier.pmid | 20375785 | - |
dc.identifier.scopus | eid_2-s2.0-77951034603 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-77951034603&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 16 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.spage | 235 | en_US |
dc.identifier.epage | 241 | en_US |
dc.identifier.isi | WOS:000276954000010 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Tang, JW=35273734900 | en_US |
dc.identifier.scopusauthorid | Shetty, N=7005372453 | en_US |
dc.identifier.scopusauthorid | Lam, TTY=36775821700 | en_US |
dc.identifier.issnl | 1070-5287 | - |